1. Home
  2. RPRX vs CRBG Comparison

RPRX vs CRBG Comparison

Compare RPRX & CRBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • CRBG
  • Stock Information
  • Founded
  • RPRX 1996
  • CRBG 1957
  • Country
  • RPRX United States
  • CRBG United States
  • Employees
  • RPRX N/A
  • CRBG N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • CRBG Life Insurance
  • Sector
  • RPRX Health Care
  • CRBG Finance
  • Exchange
  • RPRX Nasdaq
  • CRBG Nasdaq
  • Market Cap
  • RPRX 16.2B
  • CRBG 14.2B
  • IPO Year
  • RPRX 2020
  • CRBG 2022
  • Fundamental
  • Price
  • RPRX $39.71
  • CRBG $30.27
  • Analyst Decision
  • RPRX Strong Buy
  • CRBG Buy
  • Analyst Count
  • RPRX 3
  • CRBG 13
  • Target Price
  • RPRX $46.00
  • CRBG $38.62
  • AVG Volume (30 Days)
  • RPRX 4.5M
  • CRBG 7.7M
  • Earning Date
  • RPRX 11-05-2025
  • CRBG 11-03-2025
  • Dividend Yield
  • RPRX 2.21%
  • CRBG 3.20%
  • EPS Growth
  • RPRX N/A
  • CRBG N/A
  • EPS
  • RPRX 1.75
  • CRBG 1.78
  • Revenue
  • RPRX $2,349,844,000.00
  • CRBG $18,335,000,000.00
  • Revenue This Year
  • RPRX $36.16
  • CRBG $0.38
  • Revenue Next Year
  • RPRX $2.04
  • CRBG $5.43
  • P/E Ratio
  • RPRX $22.74
  • CRBG $16.87
  • Revenue Growth
  • RPRX 3.70
  • CRBG 15.16
  • 52 Week Low
  • RPRX $24.05
  • CRBG $23.69
  • 52 Week High
  • RPRX $41.24
  • CRBG $36.57
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 59.32
  • CRBG 52.39
  • Support Level
  • RPRX $37.31
  • CRBG $27.29
  • Resistance Level
  • RPRX $40.00
  • CRBG $28.82
  • Average True Range (ATR)
  • RPRX 1.03
  • CRBG 0.87
  • MACD
  • RPRX -0.03
  • CRBG 0.15
  • Stochastic Oscillator
  • RPRX 85.66
  • CRBG 92.70

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About CRBG Corebridge Financial Inc.

Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.

Share on Social Networks: